Work

Abstract 20280: Impact of the Cholesteryl Ester Transfer Protein Inhibitor Evacetrapib on Cholesterol Efflux Capacity in High Risk Patients Within the ACCELERATE Trial

Year: 2016

Type: conference-abstract

Source: Circulation

Authors: Giacomo Ruotolo, Michael Lincoff, Steven E. Nissen, Venugopal Menon, Jeffrey S. Riesmeyer, Lauren Beacham, Ellen McErlean, Daniel J. Rader, Stephen J. Nicholls

Institutions: Eli Lilly (United States), Cleveland Clinic, University of Pennsylvania, South Australian Health and Medical Research Institute, The University of Adelaide

Language: English

Topic: Lipoproteins and Cardiovascular Health

Subfield: Surgery

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2784146327

Cites:

Cited by:

Related to: 10